Mathiot et al. used the NGS technique to identify the Q61L (p.Gln61Leu, c.182A > T) mutation in the HRAS gene in four advanced NSCLC patients (0.25% of 1614 tested tumor) [55]. Here, HRAS is linked to non-small cell lung carcinoma.